Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Parkinson's disease
Pharma
Acadia gives up on future Nuplazid studies after latest flop
The company will not conduct any further clinical trials of the drug, which is currently approved for Parkinson’s disease psychosis.
Zoey Becker
Mar 12, 2024 11:58am
Bayer cuts ribbon at new cell therapy 'launch facility' in CA
Oct 10, 2023 10:51am
Fighting talk: Acorda gets combative in new Parkinson's campaign
Aug 3, 2023 8:00am
FDA shoots down Amneal's Parkinson's med
Jul 5, 2023 11:08am
Neurocrine gives up on Parkinson's drug Ongentys
May 3, 2023 10:55am
FDA snubs AbbVie's blockbuster-to-be Parkinson's drug
Mar 22, 2023 11:50am